NEW YORK--(BUSINESS WIRE)--Kirby McInerney LLP is investigating potential claims against the Board of Directors of Rochester Medical Corporation (“Rochester Medical” or the “Company”) (NASDAQ: ROCM) related to the proposed acquisition of the Company by C.R. Bard (“Bard”), a New Jersey-based medical equipment manufacturer. Under the terms of the agreement, Bard will acquire all outstanding shares of Rochester Medical for $20.00 per share in cash, for a total transaction value of approximately $262 million.
The investigation concerns whether the Rochester Medical Board of Directors violated its fiduciary duties by agreeing to this transaction and whether the proposed $20.00 per share consideration adequately values Rochester Medical common shares.
If you are a Rochester Medical (ROCM) shareholder and wish to obtain additional information, please contact J. Brandon Walker, Esq. by email at email@example.com, by telephone at (212) 699-1145 or (888) 529-4787, or by filling out this contact form.
Kirby McInerney LLP is a New York-based law firm concentrating in securities, shareholder, whistleblower, antitrust and consumer litigation. For additional information, please go to www.kmllp.com.